MedPath

Efficacy and safety of acupuncture treatment for fatigue after COVID-19 infection: a pilot randomized sham-controlled trial

Not Applicable
Completed
Conditions
Certain infectious and parasitic diseases
Registration Number
KCT0008656
Lead Sponsor
Kyung Hee University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

1) Those who have been diagnosed with COVID-19 and quarantined (and cured) at least one month ago
2) Adults between 20 and 65 years of age
3) Those who are experiencing fatigue that has persisted for more than 4 weeks after being cured of COVID-19, and whose symptom intensity of 4 or higher on the 0-10 numeric rating scale
4) Those who voluntarilly agree to participate in the study through a written consent form after being clearly explained of the purpose and characteristics of this clinical study

Exclusion Criteria

1) Those who have a history of diseases(cancer, anemia, hypothyroidism or psychiatric disease such as depression) or surgical operation that can cause sequelae before the infection of COVID-19
2) Those who have a fear of acupuncture treatment
3) Women who are pregnant, may become pregnant or are lactating
4) Those who are judged that it is difficult to comply with this treatment protocol, visiting the hospital, or filing in a questionnaire, etc.
5) Those who are participating in another clinical study
6) Subjects who are judged to be inappropriate for the clinical study by the researchers

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
0-10 numeric rating scale (NRS);Brief fatigue inventory (BFI);Fatigue severity scale(FSS);Adverse event evaluation after acupuncture treatment
Secondary Outcome Measures
NameTimeMethod
EuroQoL-5Dimension-5L (EQ-5D-5L);Concomitant medications and changes in treatment history;Study design and subject compliance to acupuncture treatment;Was it Worth It (WIWI) questionnaires;Blinding index assessment for randomization
© Copyright 2025. All Rights Reserved by MedPath